As a result, SGLT2 inhibitors are now recommended as first add-on (or even first-line, alongside metformin) when someone has established cardiovascular disease, heart failure, or chronic kidney disease: even if their HbA1c is at target
Additionally, some patients may experience changes in their dietary habits when starting these medications, such as reduced appetite or altered food choices, which can further contribute to digestive issues
Classic agonists like liraglutide, semaglutide, and dulaglutide mimic the natural signal but keep it on far longer
Greenway, U
Expert Recommendation: Which Site Is Better for You
Used propensity score matching to form two patient cohorts (GLP-1 users vs nonusers), each consisting of 38,439 patients